How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

6,129 results for

Depression Screening Tools

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

261. Transcultural adaption and psychometric properties of the STarT Back Screening Tool among Finnish low back pain patients. (Abstract)

Transcultural adaption and psychometric properties of the STarT Back Screening Tool among Finnish low back pain patients. The STarT Back Screening Tool (SBST) is a 9-item questionnaire designed for screening low back pain (LBP) patients into three prognostic groups for stratified care. The stratified care approach has proven to be clinically more beneficial and cost-effective than the current best physiotherapy practice. The objective of this study was to translate, culturally adapt and study (...) psychometric properties of the SBST among Finnish LBP patients.The SBST was translated into Finnish using appropriate translation guidelines. A total of 116 patients were recruited from outpatient clinics. They were asked to fill out two questionnaires within 1-7 days. The first questionnaire set included the SBST, Oswestry Disability Index (ODI), Beck Depression Inventory (BDI), Örebro Musculoskeletal Pain Screening Questionnaire (ÖMPSQ) and intensities of back and leg pain (10-cm Visual Analogue Scale

2015 European Spine Journal

262. Pediatric Pain Screening Tool (PPST): Rapid identification of risk in youth with pain complaints. Full Text available with Trip Pro

Pediatric Pain Screening Tool (PPST): Rapid identification of risk in youth with pain complaints. Moderate to severe chronic pain is a problem for 1.7 million children, costing $19.5 billion dollars annually in the United States alone. Risk-stratified care is known to improve outcomes in adults with chronic pain. However, no tool exists to stratify youth who present with pain complaints to appropriate interventions. The Pediatric Pain Screening Tool (PPST) presented here assesses prognostic (...) % of patients who met reference standard case status at follow-up were classified as high risk at baseline. A 9-item screening tool identifying factors associated with adverse outcomes among youth who present with pain complaints seems valid and provides risk stratification that can potentially guide effective pain treatment recommendations in the clinic setting.

2015 Pain

263. Guidelines for the screening, care and treatment of persons with chronic hepatitis C infection

and tools to define research questions, develop an analytical framework, conduct systematic reviews, assess the overall quality of the evidence, and determine the direction and strength of the recommendations. The process involved multiple steps that included the formation of a Guidelines Development Group, and the development of a series of questions across the screening, care and treatment framework, which were structured in the PICO format (Population, Intervention, Comparison, Outcomes). Systematic (...) Guidelines for the screening, care and treatment of persons with chronic hepatitis C infection GUIDELINES FOR THE SCREENING, CARE AND TREATMENT OF PERSONS WITH CHRONIC HEPATITIS C INFECTION UPDATED VERSION APRIL 2016 GUIDELINESGUIDELINES FOR THE SCREENING, CARE AND TREATMENT OF PERSONS WITH CHRONIC HEPATITIS C INFECTION UPDATED VERSION APRIL 2016 GUIDELINESWHO Library Cataloguing-in-Publication Data Guidelines for the screening care and treatment of persons with chronic hepatitis C infection

2016 World Health Organisation Guidelines

264. Screening for neuropsychological impairment in COPD patients undergoing rehabilitation. Full Text available with Trip Pro

Screening for neuropsychological impairment in COPD patients undergoing rehabilitation. Chronic obstructive pulmonary disease (COPD) is a complex multi-component disorder characterized by progressive irreversible respiratory symptoms and extrapulmonary comorbidities, including anxiety-depression and mild cognitive impairment (MCI). However, the prevalence of these impairments is still uncertain, due to non-optimal screening methods. This observational cross-sectional multicentre study aimed (...) to evaluate the prevalence of anxiety-depressive symptoms and MCI in COPD patients, identify the most appropriate cognitive tests to screen MCI, and investigate specific cognitive deficits in these patients and possible predictive factors.Sixty-five stable COPD inpatients (n = 65, aged 69.9±7.6 years, mainly stage III-IV GOLD) underwent the following assessments: Hospital Anxiety and Depression Scale (HADS), Geriatric Depression Scale (GDS) or Beck Depression Inventory-II (BDI-II), Mini-Mental State

2018 PLoS ONE

265. Depressive symptoms following natural disaster in Korea: psychometric properties of the Center for Epidemiologic Studies Depression Scale Full Text available with Trip Pro

showed adequate internal consistency, except for the 'interpersonal difficulties' subscale. Also regarding concurrent validity, weak to moderate positive correlations were observed between the KCES-D and the trauma-related measures.The results support the four-factor model and indicate that the KCES-D has adequate psychometric properties for natural disaster survivors. If these findings are further confirmed, the KCES-D can be used as a useful, rapid, and inexpensive screening tool for assessing (...) Depressive symptoms following natural disaster in Korea: psychometric properties of the Center for Epidemiologic Studies Depression Scale Depressive symptoms have been recognized as one of the most frequent complaints among natural disaster survivors. One of the most frequently used self-report measures of depressive symptoms is the Center for Epidemiologic Studies Depression Scale (CES-D). To our knowledge, no study has yet examined the factor structure, reliability, and validity of the CES-D

2017 Health and quality of life outcomes

266. The criterion validity of the web-based Major Depression Inventory when used on clinical suspicion of depression in primary care Full Text available with Trip Pro

The criterion validity of the web-based Major Depression Inventory when used on clinical suspicion of depression in primary care The Major Depression Inventory (MDI) is widely used in Danish general practice as a screening tool to assess depression in symptomatic patients. Nevertheless, no validation studies of the MDI have been performed. The aim of this study was to validate the web-based version of the MDI against a fully structured telephone interview in a population selected on clinical (...) suspicion of depression (ie, presence of two or three core symptoms of depression) in general practice.General practitioners (GPs) invited consecutive persons suspected of depression to complete the web-based MDI in a primary care setting. The validation was based on the Munich-Composite International Diagnostic Interview (M-CIDI) by phone. GPs in the 22 practices in our study included 132 persons suspected of depression. Depression was rated as yes/no according to the MDI and M-CIDI. Sensitivity

2017 Clinical epidemiology

267. Cardiac Screening With Electrocardiography, Stress Echocardiography, or Myocardial Perfusion Imaging: Advice for High-Value Care From the American College of Physicians

of persons aged 50 years estimated a risk of 2 to 25 additional cancer cases per 10 000 MPI scans ( ), depending on the imaging technique and tracers used. Harms may also occur due to false-positive results. In low-prevalence populations, even screening tests with high sensitivity and specificity are associated with a low positive predictive value (high rate of false-positive results) ( ). Up to three quarters of asymptomatic men with exercise-induced ST-segment depression on ECG have no significant (...) Cardiac Screening With Electrocardiography, Stress Echocardiography, or Myocardial Perfusion Imaging: Advice for High-Value Care From the American College of Physicians Cardiac Screening in Low-Risk Adults | Annals of Internal Medicine | American College of Physicians '); } Sign in below to access your subscription for full content INDIVIDUAL SIGN IN | You will be directed to acponline.org to register and create your Annals account INSTITUTIONAL SIGN IN | | Subscribe to Annals of Internal

2015 American College of Physicians

268. Abnormal Blood Glucose and Type 2 Diabetes Mellitus: Screening

at . For a summary of the evidence systematically reviewed in making this recommendation, the full recommendation statement, and supporting documents, please go to . Abbreviations: IFG = impaired fasting glucose; IGT = impaired glucose tolerance. Additional Information - Educational Tools Screening for Abnormal Blood Glucose and Type 2 Diabetes: Consumer Guide | (January 2014) (April 2015) (April 2015) Recommendation Information Table of Contents PDF Version and JAMA Link Archived Versions View (...) and depression among people attending diabetes screening: a prospective cohort study embedded in the ADDITION (Cambridge) randomized control trial. Br J Health Psychol . 2011;16(Pt 1):213-26. 39. Davies MJ, Heller S, Skinner TC, Campbell MJ, Carey ME, Cradock S, et al; Diabetes Education and Self Management for Ongoing and Newly Diagnosed Collaborative. Effectiveness of the Diabetes Education and Self Management for Ongoing and Newly Diagnosed (DESMOND) programme for people with newly diagnosed type 2

2015 U.S. Preventive Services Task Force

269. A Transdiagnostic Sleep and Circadian Treatment for Major Depressive Disorder

Measures : Change in Hospital Anxiety and Depression Scale (HADS) [ Time Frame: Pre-treatment, 1-week post-treatment and 12-week post treatment ] A 14-item self-rating scale that measures anxiety and depression in both hospital and community settings. It is divided into an Anxiety subscale (HADS-A) and a Depression subscale (HADS-D) both containing seven intermingled items. It is for screening purpose and not meant to be a diagnostic tool. HADS scores of 8-10, 11-14, and 15-21 represent mild, moderate (...) Measures Go to Primary Outcome Measures : Change in the Patient Health Questionnaire (PHQ-9) [ Time Frame: Pre-treatment, 1-week post-treatment and 12-week post treatment ] The PHQ-9, a 20-item questionnaire used for screening, diagnosing, monitoring and measuring the severity of depression, which scores each of the nine DSM-IV criteria as "0" (not at all) to "3" (nearly every day). PHQ-9 scores of 5, 10, 15, and 20 represents mild, moderate, moderately severe and severe depression Secondary Outcome

2018 Clinical Trials

270. Validating the Geriatric Depression Scale with proxy-based data: A case-control psychological autopsy study in rural China. (Abstract)

. For suicide cases, the GDS-30 showed the highest Youden's index as 34.86% with a cut-off value at 22, when its sensitivity and specificity was 0.78 and 0.56, respectively; the score of 12 on the GDS-15 showed the highest Youden's index of 31.39%, and its sensitivity and specificity was 0.74 and 0.58, respectively.This study is limited to its generalizability to Chinese urban elderly with psychological autopsy method.The GDS-30 and the GDS-15 were both valid tools for measuring the severity of depressive (...) symptoms rather than screening for major depression in psychological autopsy research in rural China. The GDS-15 can be considered as a good substitute for the GDS-30.Copyright © 2018. Published by Elsevier B.V.

2018 Journal of Affective Disorders

271. Feasibility of the Post-Stroke Depression-toolkit

assessment tools for the early detection of depression after stroke, and a set of interventions in case of a positive screening for (risk on) depressive symptoms. Objective: to investigate the feasibility of the Post Stroke Depression-toolkit in daily practice. Study design: An explanatory mixed-methods, before-and-after study design. Study population: Nurses working on the neurological wards of one university hospital and two general hospitals in the Netherlands were included in the study. Additionally (...) of Applied Sciences Utrecht Study Details Study Description Go to Brief Summary: Rationale: Depression is a frequent complication after a stroke. In stroke guidelines several recommendations focus on early screening, and treatment off depression after stroke. Introducing clinical practice guidelines into routine daily practice however, is a difficult process. In order to make the recommendations applicable to clinical practice a toolkit was developed (the Post Stroke Depression-toolkit), which provides

2018 Clinical Trials

272. A Neurosteroid Intervention for Menopausal and Perimenopausal Depression

Psychiatric disorder other than MDD that is acute and the primary focus of symptom burden or treatment. History of bipolar disorder or psychotic disorder Current substance use disorder Positive baseline urine drug screen of an illicit substance with the exception of a medication used with a prescription such as an opioid pain medication Current eating disorder Treatment resistant depression (failure of 2 adequate antidepressant trials or electroconvulsive therapy (ECT) during current episode; adequate (...) A Neurosteroid Intervention for Menopausal and Perimenopausal Depression A Neurosteroid Intervention for Menopausal and Perimenopausal Depression - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more

2018 Clinical Trials

273. Telematic Program for the Treatment of Depression in Type 1 Diabetes

performed in people with diabetes and depression. However, the need to provide professionals with adequate tools to help people with this problem is justified. The main objective of this project is to apply a telematic program for the treatment of specific depression for people with type 1 diabetes designed by our research team in a sample of patients with type 1 diabetes and mild-moderate depressive symptomatology of the province of Malaga. To do this, the sample will be divided into two groups (...) ), 3, 6 and 12 months. ] Beck Depression Inventory-Fast Screen (BDI-FS) Secondary Outcome Measures : Fear of Hypoglycemia [ Time Frame: Pre treatment, post treatment (12 weeks), 3, 6 and 12 months. ] Fear of Hypoglycemia Scale (FH-15): 15 summable items assessed on a 5-point Likert scale with a range of 1-5. The cutoff score was set at 28 points. Individuals with scores equal to or greater than 28 points will be classified as having fear of hypoglycemia. Distress [ Time Frame: Pre treatment, post

2018 Clinical Trials

274. Umbilical Cord Milking in Neonates Who Are Depressed at Birth-Developmental Follow Up (MIDAB-FU)

Umbilical Cord Milking in Neonates Who Are Depressed at Birth-Developmental Follow Up (MIDAB-FU) Umbilical Cord Milking in Neonates Who Are Depressed at Birth-Developmental Follow Up (MIDAB-FU) - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one (...) or more studies before adding more. Umbilical Cord Milking in Neonates Who Are Depressed at Birth-Developmental Follow Up (MIDAB-FU) (MIDAB-FU) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03681314 Recruitment Status

2018 Clinical Trials

275. Efficacy of Light Therapy Device LUMINETTE® in Major Depressive Disorder

] Self reported rating scale measuring day time sleepiness Hamilton Anxiety Rating Scale (HAM-A) [ Time Frame: week 8 ] Tool measuring the severity of anxiety symptoms. Other Outcome Measures: electroretinogramm [ Time Frame: at inclusion, week 4,8 and 12 ] test that measure the functional activity of the retina Hopkins Verbal Learning Test (HVLT) [ Time Frame: week 10 ] test of verbal Learning and memory Montreal Cognitive Assessment (MoCA) [ Time Frame: week 10 ] screening assessment for detecting (...) Efficacy of Light Therapy Device LUMINETTE® in Major Depressive Disorder Efficacy of Light Therapy Device LUMINETTE® in Major Depressive Disorder - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Efficacy

2018 Clinical Trials

276. Accelerated Intermittent Theta Burst Stimulation for Inpatients With Major Depressive Disorder (aiTBS)

Accelerated Intermittent Theta Burst Stimulation for Inpatients With Major Depressive Disorder (aiTBS) Accelerated Intermittent Theta Burst Stimulation for Inpatients With Major Depressive Disorder (aiTBS) - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please (...) remove one or more studies before adding more. Accelerated Intermittent Theta Burst Stimulation for Inpatients With Major Depressive Disorder (aiTBS) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03693105 Recruitment

2018 Clinical Trials

277. Meditation Based Lifestyle Modification in Depression

-8 is a global, one-dimensional patient satisfaction measurement tool. It is the German-language adaptation of the American CSQ-8 by Attkisson & Zwick (1982). Over eight items, the general satisfaction with aspects of the clinic or the received treatment is recorded. ZUF-8 is particularly suitable for economical screening of patient satisfaction (Schmidt, Lamprecht, & Wittmann, 1989). Perseverative Thinking Questionnaire (PTQ) [ Time Frame: Baseline, 8 weeks, 24 weeks ] The PTQ (Ehring et al (...) Meditation Based Lifestyle Modification in Depression Meditation Based Lifestyle Modification in Depression - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Meditation Based Lifestyle Modification

2018 Clinical Trials

278. Clinical and Neurobiological Profile Predictive of Pejorative Outcome of Depression

(Continuous Performance Test III): assessment of the patient's attentional abilities. This tool is computerized. It is suggested to the patient to hold his attention for 20 minutes. Letters appear on a screen at different speeds and rhythms. The patient must click on the space bar as quickly as possible at each appearance of letters except when the letter X is displayed. The scores evaluate the reaction time as well as the number of errors. IRM [ Time Frame: At baseline and at 36 months ] Neuroimaging (...) Clinical and Neurobiological Profile Predictive of Pejorative Outcome of Depression Clinical and Neurobiological Profile Predictive of Pejorative Outcome of Depression - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before

2018 Clinical Trials

279. Lifestyle Medicine for Depression

: Baseline, 1-week post-treatment and 12-week post treatment ] The PHQ-9, a 20-item questionnaire used for screening, diagnosing, monitoring and measuring the severity of depression, which scores each of the nine DSM-IV criteria as "0" (not at all) to "3" (nearly every day). Secondary Outcome Measures : Change in Insomnia Severity Index (ISI) [ Time Frame: Baseline, 1-week post-treatment and 12-week post treatment ] ISI is a 7-item scale designed to evaluate perceived insomnia severity. Ratings on the 5 (...) of general fatigue, physical fatigue, mental fatigue, reduced motivation and reduced activity. Change in Sheehan Disability Scale (SDS) [ Time Frame: Baseline, 1-week post-treatment and 12-week post treatment ] SDS is a brief, 5-item self-report tool that assesses functional impairment in work/school, social life, and family life Change in Depression Anxiety Stress Scales (DASS-21) [ Time Frame: Baseline, 1-week post-treatment and 12-week post treatment ] DASS-21 is a 21-items scales, comprises three sub

2018 Clinical Trials

280. Depression, malnutrition, and health-related quality of life among Nepali older patients. Full Text available with Trip Pro

-sectional survey was conducted from January-April of 2017 among 289 Nepali older patients in an outpatient clinic at Nepal Medical College in Kathmandu. Nutritional status, depression and HRQOL were assessed using a mini nutritional assessment, geriatric depression scales, and the European quality of life tool, respectively. Linear regression models were used to find the factors associated with nutritional status, depression, and HRQOL. The potential mediating and moderating role of nutritional status (...) , nutritional status mediated 41% of the total effect of depression on HRQOL, while depression mediated 6.0% of the total effect of the nutrition on HRQOL.A sizeable proportion of older patients had malnutrition and depression. Given that nutritional status had a significant direct (independently) and indirect (as a mediator) effect on HRQOL, we believe that nutritional screening and optimal nutrition among the older patients can make a significant contribution to the health and well-being of Nepali older

2018 BMC Geriatrics

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>